Eli Lilly: Goldman Sachs raised the target price from $740 to $785
礼来：高盛将目标价从740美元上调至785美元
Eli Lilly: Goldman Sachs raised the target price from $740 to $785
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.